Literature DB >> 17230202

Advocacy groups as research organizations: the PXE International example.

Sharon F Terry1, Patrick F Terry, Katherine A Rauen, Jouni Uitto, Lionel G Bercovitch.   

Abstract

Advocacy organizations for genetic diseases are increasingly becoming involved in biomedical research, particularly translational research, in order to meet the needs of the individuals that they serve. PXE International, an advocacy organization for the disease pseudoxanthoma elasticum, provides an example of how research can be accelerated by these groups. It has adopted methods that were pioneered by other advocacy organizations, and has integrated these along with new approaches into franchizable elements. The model has been followed for other conditions and has led to the establishment of a common infrastructure to enable advocacy groups to initiate, conduct and accelerate research.

Entities:  

Mesh:

Year:  2007        PMID: 17230202     DOI: 10.1038/nrg1991

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  47 in total

1.  Commentary: a sociologist's view on community genetics.

Authors:  Aviad E Raz
Journal:  J Community Genet       Date:  2010-02-25

2.  When patients march in.

Authors:  Virginia Hughes
Journal:  Nat Biotechnol       Date:  2010-11       Impact factor: 54.908

3.  Exploring the positions of German and Israeli patient organizations in the bioethical context of end-of-life policies.

Authors:  Aviad Raz; Isabella Jordan; Silke Schicktanz
Journal:  Health Care Anal       Date:  2014-06

4.  Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.

Authors:  Katherine A Rauen; Anuradha Banerjee; W Robert Bishop; Jennifer O Lauchle; Frank McCormick; Martin McMahon; Teri Melese; Pamela N Munster; Sorena Nadaf; Roger J Packer; Judith Sebolt-Leopold; David H Viskochil
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-04-14       Impact factor: 3.908

5.  The contractual genome: how direct-to-consumer genomic services may help patients take ownership of their DNA.

Authors:  Morris W Foster; Richard R Sharp
Journal:  Per Med       Date:  2008-07-01       Impact factor: 2.512

6.  Addressing Deficits and Injustices: The Potential Epistemic Contributions of Patients to Research.

Authors:  Katrina Hutchison; Wendy Rogers; Vikki A Entwistle
Journal:  Health Care Anal       Date:  2017-12

Review 7.  Pseudoxanthoma elasticum: progress in diagnostics and research towards treatment : Summary of the 2010 PXE International Research Meeting.

Authors:  Jouni Uitto; Lionel Bercovitch; Sharon F Terry; Patrick F Terry
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

8.  Examining Physician Interactions with Disease Advocacy Organizations.

Authors:  Caroline Horrow; Joel E Pacyna; Carol Cosenza; Richard R Sharp
Journal:  AJOB Empir Bioeth       Date:  2019-08-26

Review 9.  Ethical, legal, social, and policy implications of behavioral genetics.

Authors:  Colleen M Berryessa; Mildred K Cho
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-02-28       Impact factor: 8.929

10.  Planning for translational research in genomics.

Authors:  Naomi Hawkins; Jantina de Vries; Paula Boddington; Jane Kaye; Catherine Heeney
Journal:  Genome Med       Date:  2009-09-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.